Meiru Zhao

23.0k total citations
11 papers, 130 citations indexed

About

Meiru Zhao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meiru Zhao has authored 11 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meiru Zhao's work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Genomics and Phylogenetic Studies (3 papers). Meiru Zhao is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Genomics and Phylogenetic Studies (3 papers). Meiru Zhao collaborates with scholars based in China and United States. Meiru Zhao's co-authors include Nianzhi Jiao, K. Eric Wommack, Sijun Huang, Kui Wang, Feng Chen, Haiyuan Cai, Feng Chen, Xin Yi, Tao Liu and Ling Yang and has published in prestigious journals such as Applied and Environmental Microbiology, Environmental Microbiology and BMC Genomics.

In The Last Decade

Meiru Zhao

11 papers receiving 127 citations

Peers

Meiru Zhao
Mary Barter United States
James E. J. Bedard United States
S. Fuma Japan
Bridget Shaner United States
Niels Jahn Germany
Meiru Zhao
Citations per year, relative to Meiru Zhao Meiru Zhao (= 1×) peers Aradhita Baral

Countries citing papers authored by Meiru Zhao

Since Specialization
Citations

This map shows the geographic impact of Meiru Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiru Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiru Zhao more than expected).

Fields of papers citing papers by Meiru Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiru Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiru Zhao. The network helps show where Meiru Zhao may publish in the future.

Co-authorship network of co-authors of Meiru Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Meiru Zhao. A scholar is included among the top collaborators of Meiru Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiru Zhao. Meiru Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhao, Wenhao, Chen Ding, Meiru Zhao, et al.. (2024). Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma. Journal of Cancer. 15(6). 1568–1582. 3 indexed citations
2.
Ding, Lu, Meiru Zhao, Juan Hou, et al.. (2024). Recent advances in the potential effects of natural products from traditional Chinese medicine against respiratory diseases targeting ferroptosis. Chinese Medicine. 19(1). 49–49. 6 indexed citations
3.
Ding, Lu, Guangwen Liu, Meiru Zhao, et al.. (2023). The protective effects of baicalin for respiratory diseases: an update and future perspectives. Frontiers in Pharmacology. 14. 1129817–1129817. 13 indexed citations
4.
Chen, Xiaohong, ­Jun Li­, Yinpeng Xie, et al.. (2022). Identification of DNA methylation and genetic alteration simultaneously from a single blood biopsy. Genes & Genomics. 45(5). 627–635. 4 indexed citations
5.
Wang, Jing, Guanwen Liu, Lu Ding, et al.. (2022). Protective Effects of the Wenfei Buqi Tongluo Formula on the Inflammation in Idiopathic Pulmonary Fibrosis through Inhibiting the TLR4/MyD88/NF‐κB Pathway. BioMed Research International. 2022(1). 3 indexed citations
6.
Liu, Donglai, Haiwei Zhou, Dawei Shi, et al.. (2018). Quality Control of Next-generation Sequencing-based In vitro Diagnostic Test for Onco-relevant Mutations Using Multiplex Reference Materials in Plasma. Journal of Cancer. 9(9). 1680–1688. 7 indexed citations
7.
Lv, Xiaoxing, Meiru Zhao, Yuting Yi, et al.. (2017). Detection of Rare Mutations in CtDNA Using Next Generation Sequencing. Journal of Visualized Experiments. 19 indexed citations
8.
Lv, Xiaoxing, Meiru Zhao, Yuting Yi, et al.. (2017). Detection of Rare Mutations in CtDNA Using Next Generation Sequencing. Journal of Visualized Experiments. 4 indexed citations
9.
Jiang, Hui, Cong Li, Meiru Zhao, et al.. (2012). Comprehensive evaluation of SNP identification with the Restriction Enzyme-based Reduced Representation Library (RRL) method. BMC Genomics. 13(1). 77–77. 10 indexed citations
10.
Chen, Feng, Kui Wang, Sijun Huang, et al.. (2009). Diverse and dynamic populations of cyanobacterial podoviruses in the Chesapeake Bay unveiled through DNA polymerase gene sequences. Environmental Microbiology. 11(11). 2884–2892. 48 indexed citations
11.
Zhao, Meiru, Feng Chen, & Nianzhi Jiao. (2008). Genetic Diversity and Abundance of Flavobacterial Proteorhodopsin in China Seas. Applied and Environmental Microbiology. 75(2). 529–533. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026